Immuneel Therapeutics unveils Qartemi for CAR-T cancer therapy in India
Immuneel Therapeutics, the start-up, backed by Kiran Mazumdar-Shaw, was the first in India to conduct CAR T-cell therapy ...
Immuneel’s internationally-benchmarked CAR-T cell therapy for Non-Hodgkin’s Lymphoma, is one-tenth US cost: CEO
Immuneel Therapeutics launches affordable CAR-T therapy Qartemi for B-cell Non-Hodgkin Lymphoma, aiming to revolutionize ...